Clinical Trials Directory

Trials / Completed

CompletedNCT06067997

Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE)

Status
Completed
Phase
Study type
Observational
Enrollment
550 (actual)
Sponsor
Società Italiana di Medicina di Emergenza-Urgenza · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Estimation of the incidence of pulmonary embolism in patients presenting to the Emergency Department with hemoptysis.

Detailed description

Multicenter prospective observational cross-sectional study with non-commercial (non-profit) objectives. The study population consists of consecutive patients who present to the Emergency Departments of the participating hospitals with hemoptysis. The diagnosis of pulmonary embolism will be made using the diagnostic algorithm suggested by the 2019 European guidelines. The pre-test clinical probability of pulmonary embolism will be defined based on the simplified Wells score, which classifies pulmonary embolism as "likely" or "unlikely". In patients with a low pre-test clinical probability ("unlikely") and a D-dimer level below the threshold value (negative), the diagnosis of pulmonary embolism will be excluded, and further testing will not be necessary in this regard. The D-dimer level will be measured using the quantitative assay routinely used in each participating center; the threshold value for a positive result compared to a negative result is 500 μg per milliliter for patients under 50 years of age. For each additional decade of age, the exclusion cutoff will increase by 100 μg per milliliter. For patients with a high pre-test clinical probability ("likely"), a positive D-dimer test, or both, a pulmonary CT angiography will be the diagnostic test of choice. The criterion for the presence of pulmonary embolism is the detection of an intraluminal filling defect on CT.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTpulmonary embolism diagnosisThe diagnosis of pulmonary embolism will be made using the diagnostic algorithm suggested by the 2019 European guidelines . The pre-test clinical probability of pulmonary embolism will be defined based on the simplified Wells score. In patients with a low pre-test clinical probability and a D-dimer level below the threshold value the diagnosis of pulmonary embolism will be excluded. The D-dimer level will be measured using the quantitative assay routinely used in each participating center; the threshold value for a positive result compared to a negative result is 500 μg per milliliter for patients under 50 years of age. For each additional decade of age, the exclusion cutoff will increase by 100 μg per milliliter. The criterion for the presence of pulmonary embolism is the detection of an intraluminal filling defect on CT.

Timeline

Start date
2019-12-01
Primary completion
2023-04-30
Completion
2023-08-30
First posted
2023-10-05
Last updated
2023-10-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06067997. Inclusion in this directory is not an endorsement.